Changes in Beneficial Ownership · 4
DexCom, Inc.
DXCMNASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
wk-form4_1789072814.xml
Filing details
- Report period
- 2026-09-10
- Issuer
- DEXCOM INC
- Issuer CIK
- 0001093557
- Trading symbol
- DXCM
Reporting owner 1
- Name
- Boehnlein Glenn S
- Reporting owner CIK
- 0001670936
- Relationship
- Director
- Address
- 6340 SEQUENCE DRIVE, SAN DIEGO, CA, 92121
Non-derivative transactions
| Security | Transaction date | Code | Amount | A / D | Price (USD) | Owned after | Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | 2026-09-10 | A · Form 4 | 5,841[F1] | A | 0 | 5,841 | D |
Table key
- A · Form 4
- Acquisition by grant, award or otherwise under Rule 16b-3(d)
- A
- Acquired
- D
- Direct
Non-derivative holdings
| Security | Amount owned | Ownership | Nature of ownership |
|---|---|---|---|
| Common Stock | 42 | I | By Trust[F2] |
Table key
- I
- Indirect
Footnotes
- F1
- Represents a grant of restricted stock units that are exempt from Section 16b-3 and are subject to vesting in three equal annual installments from the date of grant. Restricted stock units represent a contingent right to receive one share of DexCom, Inc. Common Stock.↩ 1
- F2
- Shares are held by the Boehnlein 2017 Trust, with respect to which the Reporting Person and the Reporting Person's spouse are co-trustees.↩ 1
Signature 1
- Signed
- /s/ Jereme M. Sylvain, as Attorney-in-Fact for Glenn S. Boehnlein
- Date
- 2026-09-10